Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2 Study of IGM-2323 in Diffuse-large-B-cell-lymphoma

X
Trial Profile

A Phase 2 Study of IGM-2323 in Diffuse-large-B-cell-lymphoma

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Imvotamab (Primary)
  • Indications Diffuse large B cell lymphoma
  • Focus Registrational; Therapeutic Use
  • Sponsors IGM Biosciences
  • Most Recent Events

    • 08 Aug 2022 According to an IGM Biosciences media release, the company expects to provide an initial efficacy and safety update from this study later this year or in the first quarter of 2023.
    • 29 Mar 2022 Status changed from planning to recruiting, according to a IGM Biosciences media release.
    • 29 Mar 2022 According to an IGM Biosciences media release, data from this study could potentially be used as the basis for accelerated review and approval of IGM-2323.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top